Literature DB >> 23889186

Minimally invasive lateral retroperitoneal transpsoas interbody fusion for L4-5 spondylolisthesis: clinical outcomes.

Amir Ahmadian1, Sean Verma, Gregory M Mundis, Rod J Oskouian, Donald A Smith, Juan S Uribe.   

Abstract

OBJECT: In this study the authors report on the clinical outcomes, safety, and efficacy of lateral retroperitoneal transpsoas minimally invasive surgery-lumbar interbody fusion (MIS-LIF) at the L4-5 disc space in patients with spondylolisthesis. This approach has become an increasingly popular means of fusion. Its most frequent complication is lumbar plexus injury. Reported complication rates at the L4-5 disc space vary widely in the literature, bringing into question the safety of MIS-LIF for the L4-5 region, especially in patients with spondylolisthesis.
METHODS: The authors retrospectively reviewed prospectively acquired multicenter databases of patients with Grade I and II L4-5 spondylolisthesis who had undergone elective MIS-LIF between 2008 and 2011. Clinical follow-up had been scheduled for 1, 3, 6, 12, and 24 months postoperatively. Outcome measures included estimated blood loss, operative time, length of hospital stay, integrity of construct, complications, fusion rates, visual analog scale (VAS), Oswestry Disability Index (ODI), and 36-Item Short Form Health Survey (SF-36).
RESULTS: Eighty-four patients with L4-5 MIS-LIF were identified, 31 of whom met the study inclusion criteria: 26 adults with Grade I and 5 adults with Grade II L4-5 spondylolisthesis who had undergone elective MIS-LIF and subsequent posterior percutaneous pedicle screw fixation without surgical manipulation of the posterior elements (laminectomy, foraminotomy, facetectomy). The study cohort consisted of 9 males (29%) and 22 females (71%) with an average age of 61.5 years. The mean total blood loss was 94 ml (range 20-250 ml). The mean hospital stay and follow-up were 3.5 days and 18.2 months, respectively. The average score on the ODI improved from 50.4 preoperatively to 30.9 at the last follow-up (p < 0.0001). The SF-36 score improved from 38.1 preoperatively to 59.5 at the last follow-up (p < 0.0001). The VAS score improved from 69.9 preoperatively to 38.7 at the last follow-up (p < 0.0001). No motor weakness or permanent deficits were documented in any patient. Correction of deformity did not have any neurological complications. All patients had improvement in anterolisthesis. Residual postoperative listhesis across cases was noted in 4 patients (12.9%). Transient anterior thigh numbness (Sensory Dermal Zone III) was noted in 22.5% of patients.
CONCLUSIONS: With its established surgical corridors through the retroperitoneum and psoas muscle, the MIS-LIF combined with posterior percutaneous pedicle screw fixation/reduction is a safe, reproducible, and effective technique for patients with symptomatic degenerative spondylolisthesis at the L4-5 vertebral segment.

Entities:  

Mesh:

Year:  2013        PMID: 23889186     DOI: 10.3171/2013.6.SPINE1340

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  22 in total

1.  Perioperative outcomes in minimally invasive lumbar spine surgery: A systematic review.

Authors:  Branko Skovrlj; Patrick Belton; Hekmat Zarzour; Sheeraz A Qureshi
Journal:  World J Orthop       Date:  2015-12-18

2.  Caudal vertebral body fractures following lateral interbody fusion in nonosteoporotic patients.

Authors:  Gabriel C Tender
Journal:  Ochsner J       Date:  2014

Review 3.  MIS lateral spine surgery: a systematic literature review of complications, outcomes, and economics.

Authors:  Jeff A Lehmen; Edward J Gerber
Journal:  Eur Spine J       Date:  2015-04-08       Impact factor: 3.134

4.  South Korean degenerative spondylolisthesis patients had surgical treatment at earlier age than Japanese, American, and European patients: a published literature observation.

Authors:  Zoltán Káplár; Yì-Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2016-12

5.  A radiographic analysis of cage positioning in lateral transpsoas lumbar interbody fusion.

Authors:  Timothy L T Siu; Elmira Najafi; Kainu Lin
Journal:  J Orthop       Date:  2016-11-22

Review 6.  Lateral Lumbar Interbody Fusion-Outcomes and Complications.

Authors:  Stephan N Salzmann; Jennifer Shue; Alexander P Hughes
Journal:  Curr Rev Musculoskelet Med       Date:  2017-12

Review 7.  Minimally invasive anterior, lateral, and oblique lumbar interbody fusion: a literature review.

Authors:  David S Xu; Corey T Walker; Jakub Godzik; Jay D Turner; William Smith; Juan S Uribe
Journal:  Ann Transl Med       Date:  2018-03

Review 8.  Clinical outcomes after minimally invasive transforaminal lumbar interbody fusion and lateral lumbar interbody fusion for treatment of degenerative lumbar disease: a systematic review and meta-analysis.

Authors:  Gun Keorochana; Kitipong Setrkraising; Patarawan Woratanarat; Alisara Arirachakaran; Jatupon Kongtharvonskul
Journal:  Neurosurg Rev       Date:  2016-12-24       Impact factor: 3.042

9.  Biomechanics of an Expandable Lumbar Interbody Fusion Cage Deployed Through Transforaminal Approach.

Authors:  Michael Conti Mica; Leonard I Voronov; Gerard Carandang; Robert M Havey; Bartosz Wojewnik; Avinash G Patwardhan
Journal:  Int J Spine Surg       Date:  2017-08-01

10.  Biomechanics of an Expandable Lumbar Interbody Fusion Cage Deployed Through Transforaminal Approach.

Authors:  Michael Conti Mica; Leonard I Voronov; Gerard Carandang; Robert M Havey; Bartosz Wojewnik; Avinash G Patwardhan
Journal:  Int J Spine Surg       Date:  2018-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.